| Understanding melanocyte stem cells for disease modeling and regenerative medicine applications AN Mull, A Zolekar, YC Wang International journal of molecular sciences 16 (12), 30458-30469, 2015 | 52 | 2015 |
| Structural and functional insights into the bona fide catalytic state of Streptococcus pyogenes Cas9 HNH nuclease domain Z Zuo, A Zolekar, K Babu, VJT Lin, HS Hayatshahi, R Rajan, YC Wang, ... Elife 8, e46500, 2019 | 29 | 2019 |
| Stress and interferon signalling-mediated apoptosis contributes to pleiotropic anticancer responses induced by targeting NGLY1 A Zolekar, VJT Lin, NM Mishra, YY Ho, HS Hayatshahi, A Parab, ... British Journal of Cancer 119 (12), 1538-1551, 2018 | 23 | 2018 |
| Impact of socioeconomic status and rurality on cancer-specific survival among women with de novo metastatic breast cancer by race/ethnicity HC Huang, MH Smart, A Zolekar, H Deng, CC Hubbard, KF Hoskins, ... Breast cancer research and treatment 193 (3), 707-716, 2022 | 12 | 2022 |
| Rational engineering of CRISPR-Cas9 nuclease to attenuate position-dependent off-target effects Z Zuo, K Babu, C Ganguly, A Zolekar, S Newsom, R Rajan, YC Wang, ... The CRISPR journal 5 (2), 329-340, 2022 | 12 | 2022 |
| Urine sample-derived cerebral organoids suitable for studying neurodevelopment and pharmacological responses VJT Lin, J Hu, A Zolekar, LJ Yan, YC Wang Frontiers in Cell and Developmental Biology 8, 304, 2020 | 11 | 2020 |
| Deficiency of N-glycanase 1 perturbs neurogenesis and cerebral development modeled by human organoids VJT Lin, J Hu, A Zolekar, MR Salick, P Mittal, JT Bird, P Hoffmann, ... Cell Death & Disease 13 (3), 262, 2022 | 8 | 2022 |
| Potassium as a pluripotency-associated element identified through inorganic element profiling in human pluripotent stem cells VJT Lin, A Zolekar, Y Shi, B Koneru, S Dimitrijevich, AJ Di Pasqua, ... Scientific reports 7 (1), 5005, 2017 | 7 | 2017 |
| Changing from mandatory to optional genotyping results in higher acceptance of pharmacist-guided warfarin dosing A Zolekar, K Kim, JC Lee, J Han, JD Duarte, WL Galanter, LH Cavallari, ... Pharmacogenomics 23 (2), 85-95, 2022 | 1 | 2022 |
| Racial differences in the impact of socioeconomic status on cancer-specific survival in multiple myeloma H Deng, A Zolekar, HC Huang, MH Smart, CC Hubbard, BC Chiu, ... Cancer Research 81 (13_Supplement), 2628-2628, 2021 | 1 | 2021 |
| Racial and ethnic differences in the impacts of rurality on cancer-specific survival among women with de novo metastatic breast cancer MH Smart, HC Huang, A Zolekar, H Deng, CC Hubbard, K Hoskins, ... Cancer Research 81 (13_Supplement), 775-775, 2021 | 1 | 2021 |
| Targeting protein deglycosylation as a newly identified vulnerable point in melanoma VJT Lin, A Zolekar, NM Mishra, YY Ho, HS Hayatshahi, A Parab, ... Cancer Research 79 (13_Supplement), 3048-3048, 2019 | 1 | 2019 |
| Socioecologic Factors and Racial Differences in Breast Cancer Multigene Prognostic Scores in US Women AZ Parab, A Kong, TA Lee, K Kim, EA Nutescu, KC Malecki, KF Hoskins, ... JAMA Network Open 7 (4), e244862-e244862, 2024 | | 2024 |
| Inhibition of NGLY1 for the treatment of cancer YC Wang, VJT Lin, A Zolekar, KA Emmitte, NM Mishra, J Liu US Patent 11,779,592, 2023 | | 2023 |
| Impact of enhanced pharmacy services on adherence for patients with hypertension P Garcia, A Zolekar, A Donnelly, A Nagelli American Journal of Health-System Pharmacy 80 (19), 1336-1341, 2023 | | 2023 |
| EPH77 Association of Socioeconomic Position and Racial Disparities in Multigene Prognostic Score Measuring Breast Cancer Recurrence Risk A Zolekar, A Kong, TA Lee, K Kim, EA Nutescu, GS Calip Value in Health 26 (6), S177-S178, 2023 | | 2023 |
| Differences in impact of socioeconomic status on cancer: Specific survival in metastatic breast cancer by race/ethnicity HC Huang, MH Smart, H Deng, A Zolekar, CC Hubbard, KF Hoskins, ... Cancer Research 81 (13_Supplement), 776-776, 2021 | | 2021 |
| Risks of Second Primary Gynecologic Cancers following Ovarian Cancer Treatment in Asian Ethnic Subgroups in the United States, 2000–2016 NH Mukand, A Zolekar, NY Ko, GS Calip Cancer Epidemiology, Biomarkers & Prevention 29 (11), 2220-2229, 2020 | | 2020 |
| Identification of NGLY1-mediated protein deglycosylation as a vulnerable point in melanoma. V Lin, A Zolekar, N Mishra, YY Ho, H Hayatshahi, A Parab, R Sampat, ... CANCER RESEARCH 80 (19), 44-44, 2020 | | 2020 |
| Declines in health related quality of life among older patients with hematologic malignancies A Zolekar, NA Nabulsi, AA Asfaw, J Zhou, K Sweiss, PR Patel, BCH Chiu, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 37-37, 2020 | | 2020 |
Jin LiuUniversity of North Texas Health Science Center在 unthsc.edu 的电子邮件经过验证
